Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy

Journal of Neuroimmunology

Volumn 73, Issue 1-2, 1997, Pages 124-134

  Meléndez Vásquez, Carmen ^a   Redford, Jane ^a   Choudhary, P P ^a   Gray, Ian A ^a   Maitland, Philip ^a   Gregson, Norman A ^a   Smith, Kenneth J ^a   Hughes, Richard A C ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

antibodies; Campylobacter; chronic inflammatory demyelinating polyradiculoneuropathy; cytomegalovirus; ganglioside GM1; myelin proteins

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GANGLIOSIDE GM1; GLYCOLIPID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CAMPYLOBACTER JEJUNI; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; ANTIBODIES; CHRONIC DISEASE; DEMYELINATING DISEASES; FEMALE; GLYCOLIPIDS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYELIN PROTEINS; OSMOLAR CONCENTRATION; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED LEW; SPINAL NERVE ROOTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0343118110     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00189-0     Document Type: Article

References (59)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 41, 617-618.
2. Adam, A.M., Atkinson, P.F., Hall, S.M., Hughes, R.A.C. and Taylor, W.A. (1989) Chronic experimental allergic neuritis in Lewis rat. Neuropathol. Appl. Neurobiol. 15, 249-264.
3. Baba, H., Daune, G.C., Ilyas, A.A., Pestronk, A., Cornblath, D.R., Chaudhry, V., Griffin, J.W. and Quarles, R.H. (1989) Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. J. Neuroimmunol. 25, 143-150.
4. Bouche, P., Moulonguet, A., Ben Younes-Chennoufit, A., Adams, D., Baumannt, N., Meininger, V., Leger, J. and Said, G. (1996) Multifocal motor neuropathy with conduction block: A study of 24 patients. J. Neurol. Psychiatry, in press.
5. Connolly, A.M., Pestronk, A., Trotter, J.L., Feldman, E.L., Cornblath, D.R. and Olney, R.K. (1993) High-titer selective serum anti-b-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 43, 557-562.
6. Dalakas, M.C. and Engel, W.K. (1980) Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch. Neurol. 37, 637-640.
7. Donaghy, M., Gray, J.A., Squier, W., Kurtz, J.B., Higgins, R.M., Richardson, A.J. and Morris, P.J. (1989) Recurrent Guillain-Barré syndrome after multiple exposures to cytomegalovirus. Am. J. Med. 87, 339-341.
8. Dyck, P.J., Daube, J., O'Brien, P., Pineda, A., Low, P.A., Windebank, A.J. and Swanson, C. (1986) Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N. Engl. J. Med. 314, 461-465.
9. Dyck, P.J., Prineas, J. and Pollard, J.D. (1993) Chronic inflammatory demyelinating polyneuropathy. In: P.J. Dyck, P.K. Thomas, J.W. Griffin et al. (Eds.), Peripheral Neuropathy, W.B. Saunders Company, Philadelphia, pp. 1498-1517.
10. Dyck, P.J., Litchy, W.J., Kratz, K.M., Suarez, G.A., Low, P.A., Pineda, A.A., Windebank, A.J., Karnes, J.L. and O'Brien, P.C. (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 36, 838-845.
11. Exley, A.R., Smith, N. and Winer, J.B. (1994) Tumour necrosis factor-a and other cytokines in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 57, 1118-1120.
12. Fredman, P., Vedeler, C.A., Nyland, H., Aarli, J.A. and Svennerholm, L. (1991) Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J. Neurol. 238, 75-79.
13. Gregson, N.A., Jones, D., Thomas, P.K. and Willison, H.J. (1991) Acute motor neuropathy with antibodies to GM1 ganglioside. J. Neurol. 238, 447-451.
14. Harrison, B.M., Hansen, L.A., Pollard, J.D. and McLeod, J.G. (1984) Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann. Neurol. 15, 163-170.
15. Hartung, H.-P., Hughes, R.A.C., Taylor, W.A., Heininger, K., Reiners, K. and Toyka, K.V. (1990) T-cell activation in Guillain-Barré syndrome and in MS: Elevated serum levels of soluble IL-2 receptors. Neurology 40, 215-218.
16. Hartung, H.-P., Pollard, J.D., Harvey, G.K. and Toyka, K.V. (1995a) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 18, 137-153.
17. Hartung, H.-P., Pollard, J.D., Harvey, G.K. and Toyka, K.V. (1995b) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part II. Muscle Nerve 18, 154-164.
18. Harvey, G.K., Pollard, J.D., Schindhelm, K. and Antony, J. (1987) Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit. J. Neurol. Sci. 81, 215-226.
19. 1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 18, 388-394.
20. Hughes, R.A.C., Gray, I.A., Gregson, N.A., Kadlubowski, M., Kennedy, M., Leibowitz, S. and Thompson, H. (1984) Immune responses to myelin antigens in Guillain-Barré syndrome. J. Neuroimmunol. 6, 303-312.
21. Hughes, R.A.C. (1990) Guillain-Barré Syndrome. Springer-Verlag, Heidelberg.
22. Ilyas, A., Mithen, F., Dalakas, M., Wargo, M., Chen, Z., Bielory, L. and Cook, S. (1991) Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J. Neurol. Sci. 105, 108-117.
23. Ilyas, A.A., Mithen, F.A., Dalakas, M.C., Chen, Z.-W. and Cook, S.D. (1992) Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107, 111-121.
24. Khalili-Shirazi, A., Hughes, R.A.C., Brostoff, S., Linington, C. and Gregson, N. (1992) T-cell response to myelin proteins in Guillain-Barré syndrome. J. Neurol. Sci. 111, 200-203.
25. 2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 46, 245-252.
26. Koski, C.L., Sanders, M.E., Swoveland, P.T., Lawley, T.J., Shin, M.L., Frank, M.M. and Joiner, K.A. (1987) Activation of terminal components of complement on patients with Guillain-Barre syndrome and other demyelinating neuropathies. J. Clin. Invest. 80, 1492-1497.
27. Latov, N., Gross, R.B., Kastelman, J., Flanagan, T., Lamme, S., Alkaitis, D.A., Olarte, M.R., Sherman, W.H., Chess, L. and Penn, A.S. (1981) Complement fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology 31, 1530-1534.
28. Lundkvist, I., van Doorn, P.A., Vermeulen, M., Van Lint, M., Van Rood, J.J. and Brand, A. (1989) Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: Spontaneous and therapeutic. Immunol. Rev. 110, 105-117.
29. Manfredini, E., Nobile-Orazio, E., Allaria, S. and Scarlato, G. (1995) Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies. J. Neurol. Sci. 133, 79-84.
30. McCombe, P.A., Pollard, J.D. and McLeod, J.G. (1987) Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 110, 1617-1630.
31. McCombe, P.A., Pollard, J.D. and McLeod, J.G. (1988) Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy. Clin. Exp. Neurol. 25, 53-60.
32. McCombe, P.A., Wilson, R. and Prentice, R. (1992) Anti-ganglioside antibodies in peripheral neuropathy. Clin. Exp. Neurol. 29, 182-188.
33. Nobile-Orazio, E., Manfredini, E., Sgarzi, M., Spagnol, G., Allaria, S., Quadroni, M. and Scarlato, G. (1994) Serum IgG antibodies to a 35-kDa P0-related glycoprotein in motor neuron disease. J. Neuroimmunol. 53, 143-151.
34. Nobile-Orazio, E. (1996) Multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry, in press.
35. Osuntokun, B.O., Prineas, J. and Field, E.J. (1966) Immunological study of chronic polyneuropathies of undetermined cause. J. Neurol. Neurosurg. Psychiatry 29, 456-458.
36. Pestronk, A., Li, F., Griffin, J., Feldman, E.L., Cornblath, D., Trotter, J., Zhu, S., Yee, W.C., Phillips, D., Peeples, D.M. and Winslow, B. (1991) Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 41, 357-362.
37. Rankin, J. (1957) Cerebral vascular accidents in patients over the age of 60. 2. Prognosis. Scott. Med. J. 2, 200-215.
38. Redford, E.J., Hall, S.M. and Smith, K.J. (1995) Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118, 869-878.
39. 1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38, 809-816.
40. Rees, J.H., Soudain, S.E., Gregson, N.A. and Hughes, R.A.C. (1995b) A prospective case control study to investigate the relationship between Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333, 1374-1379.
41. Rostami, A.M., Burns, J.B., Eccleston, P.A., Manning, M.C., Lisak, R.P. and Silberberg, D.H. (1987) Search for antibodies to galactocerebroside in the serum and CSF in human demyelinating disorders. Ann. Neurol. 22, 381-382.
42. Saida, T., Saida, K., Silberberg, D.H. and Brown, M.K. (1981) Experimental allergic neuritis induced by galactocerebroside. Ann. Neurol. 9 (Suppl.), 87-101.
43. Santoro, M., Uncini, A., Corbo, M., Staugaitis, S.M., Thomas, F.P., Hays, A.P. and Latov, N. (1992) Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31, 385-390.
44. Schmidt, B., Toyka, K., Kiefer, R., Full, J., Hartung, H. and Pollard, J. (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve, in press.
45. Server, A.C., Lefkowith, J., Braine, H. and McKhann, G.M. (1979) Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann. Neurol. 6, 258-261.
46. Sharief, M.K., McLean, B. and Thompson, E.J. (1993) Elevated serum levels of tumor necrosis factor-a in Guillain-Barré syndrome. Ann. Neurol. 33, 591-596.
47. Simone, I.L., Annunziata, P., Maimone, D., Liguori, M., Leante, R. and Livrea, P. (1993) Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 114, 49-55.
48. Stefansson, K., Marton, L.S., Dieperink, M.E., Molinar, G.K., Schlaepfer, W.W. and Helgason, C.M. (1985) Circulating autoantibodies to the 200,000 Da protein of neurofilaments in the serum of healthy individuals. Science 228, 1117-1119.
49. Taylor, W.A. and Hughes, R.A.C. (1989) T-lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 24, 33-39.
50. Toyka, K.V., Augspach, R., Wietholter, H., Besinger, U.A., Haneveld, F., Liebert, U.G., Heininger, K., Schwendemann, G., Reiners, K. and Grabensee, B. (1982) Plasma exchange in chronic inflammatory polyneuropathy: Evidence suggestive of a pathogenic humoral factor. Muscle Nerve 5, 479-484.
51. Uncini, A., Santoro, M., Corbo, M., Lugaresi, A. and Latov, N. (1993) Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16, 610-615.
52. van der Meché, F.G.A. and van Doorn, P.A. (1995) Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy: Immune mechanisms and update on current therapies. Ann. Neurol. 37, S14-S31.
53. van Doorn, P.A., Brand, A. and Vermeulen, M. (1987) Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. Neurology 37, 1798-1802.
54. van Doorn, P.A., Brand, A. and Vermeulen, M. (1988) Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: Inhibition in vitro and in vivo by IV immunoglobulin. Neurology 38, 1592-1595.
55. van Schaik, I.N., Vermeulen, M., van Doorn, P.A. and Brand, A. (1994) Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). J. Neuroimmunol. 54, 109-115.
56. van Schaik, I.N., Vermeulen, M., van Doorn, P.A. and Brand, A. (1995) Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy. J. Neurol. 242, 599-603.
57. Winer, J.B., Hughes, R.A.C., Anderson, M.J., Jones, D.M., Kangro, H. and Watkins, R.F.P. (1988) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J. Neurol. Neurosurg. Psychiatry 51, 613-618.
58. Zielasek J., Ritter G., Magi S., et al. (1994) A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1. J. Neurol. 241, 475-480.
59. Zweiman, B., Rostami, A., Lisak, R.P., Moskovitz, A.R. and Pleasure, D.E. (1983) Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Neurology 33, 234-237.